khageswara Rao
☆    

India,
2022-01-25 07:43
(846 d 03:36 ago)

Posting: # 22756
Views: 1,786
 

 BMI Criteria for FDA [Regulatives / Guidelines]

HII all,

IN FDA it is not mentioned BMI criteria so is it we can mention BMI criteria-18.5 to 30.0 kg/m² (including both) in protocol.

Please share your inputs.
Ohlbe
★★★

France,
2022-02-02 19:42
(837 d 15:37 ago)

@ khageswara Rao
Posting: # 22769
Views: 1,545
 

 BMI Criteria for FDA

Dear Khageswara Rao,

❝ IN FDA it is not mentioned BMI criteria so is it we can mention BMI criteria-18.5 to 30.0 kg/m² (including both) in protocol.


What is written in the 2003 BE guidance is We recommend that restrictions on admission into the study generally be based solely on safety considerations.

Similarly, the 2021 draft guidance on BE for ANDA states We also recommend that any restrictions on admission into a study be primarily based on safety considerations.

OK, they have changed from solely to primarily... But BMI limits are not related to safety.

The 2003 guidance also states that This guidance recommends that in vivo BE studies be conducted in individuals representative of the general population.

So overall: if you want to use restrictive inclusion criteria, be prepared to justify them (e.g. explaining that collecting blood samples from subjects with a very high BMI may be challenging - though they could object that vein accessibility might be a more relevant inclusion criterion).

Regards
Ohlbe
khageswara Rao
☆    

India,
2022-02-03 11:47
(836 d 23:32 ago)

@ Ohlbe
Posting: # 22770
Views: 1,398
 

 BMI Criteria for FDA

Thanks for information.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5[Helmut]
UA Flag
Activity
 Admin contact
23,033 posts in 4,835 threads, 1,642 registered users;
47 visitors (0 registered, 47 guests [including 12 identified bots]).
Forum time: 12:19 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5